By Mariam Sunny (Reuters) -Biohaven said on Monday its experimental treatment for a rare neuromuscular disorder failed to significantly improve motor function in a late-stage trial, sending the shares ...

Tascosa football player Derrion Howard continues to recover from a spinal injury that caused him to lose feeling in his legs ...

The numbers Yee is talking about are from a new study released by a spinal surgeon, Dr. Brian Kwon, who noticed an alarming ...

The plaintiff's attorney said the biggest hurdle in the case had to do with proving causation, since the plaintiff had ...

As the ski season kicks off, new research from UBC is shedding light on the number of spinal cord injuries that British ...

The New Haven, Conn., biopharmaceutical company said Monday that taldefgrobep had shown clinically meaningful improvements in motor function in spinal muscular atrophy patients, but the treatment arm ...

A new study emphasizes that neighborhood conditions significantly shape recovery opportunities for individuals with SCI and advocates for environmental interventions to reduce health inequities.

Spinal cord stimulation (SCS) for treatment of chronic pain in the back and/or lower extremities is associated with greater ...

Biohaven's Phase 3 trial of taldefgrobep alfa failed to meet its primary endpoint in spinal muscular atrophy, causing a 10% ...

Spine surgery is a medical procedure aimed at treating issues with the spine such as herniated discs spinal stenosis or ...

In a breakthrough towards redefining pain management, a team of spine surgeons and pain specialists at Apollo Cancer Centre ...

Despite disappointing results in the genetic neurodegenerative disorder, the drug shows potential for treating obesity.